Macquarie Group LTD G1 Therapeutics, Inc. Transaction History

Macquarie Group LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$2.1 - $4.83 $2,809 - $6,462	1,338 New	1,338 $5,000
Q2 2022 Aug 15, 2022	SELL	$4.04 - $8.51 $3,401 - $7,165	-842 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$17.58 - $32.59 $4,535 - $8,408	-258 Reduced 23.45%	842 $20,000
Q2 2020 Aug 11, 2020	BUY	$9.57 - $24.37 $10,527 - $26,807	1,100 New	1,100 $27,000
Q1 2018 May 11, 2018	SELL	$19.05 - $41.76 $11,430 - $25,056	-600 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$19.01 - $26.2 $11,406 - $15,720	600	600 $12,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.